GeneDx Holdings Corp.

NASDAQ:WGS

Medical - Healthcare Information Services

Healthcare
$51.96 +2.69%

+$1.52 today

Market cap
$1.56B
Beta
1.97
P/E (TTM)
-21.8
EPS (TTM)
-$2.65
52W Low $32.21High $170.87

Volume 1.71M

Average 1.28M

WGS Total Liabilities

Everything the company owes to creditors and other parties.

GeneDx Holdings Corp.NASDAQ: WGS

Total Liabilities · Q2 FY2026 · quarter ended Jun 2026

Total liabilities rises 27.1% from a year ago

Total liabilities stood at $237.27M at the end of Q2 FY2026, up 27.1% from a year earlier and down 5.9% from the prior quarter. Over 3 fiscal years it compounded at -3.5% a year.

Context

  • Total liabilities amounted to 49.3% of total assets at the end of Q2 FY2026, up 9.0 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps rising in the next quarterly balance sheet after a +27.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$237.27M-5.9% QoQ
Last fiscal yearDec 2025
$262.01M+50.5% YoY
Year agoJun 2025
$186.73M+27.1% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.1%——
1 year+50.5%——
3-year CAGR-3.5%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
262.01M USD
Year-over-year change
+50.5%
4-year CAGR
+12.1%

Total Liabilities vs competitors

How WGS compares with its peers on the latest reported figures

  • WGS's Jun 2026 total liabilities of $237.27M is the 3rd highest of the 9 companies compared; the peer median is $137.35M.
  • Its year-over-year change of +27.1% is the 4th highest of 9, against a peer median of +13.2%.
  • Total liabilities amounts to 49.3% of total assets for WGS, versus a peer median of 34.1%.
WGS Competitors Peer median
Total Liabilities for WGS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NEONeoGenomics, Inc.Jun 2026$565.65M +4.8%-11.0%41.8%
MYGNMyriad Genetics, Inc.Mar 2026$336.3M +11.7%+2.7%49.9%
WGSGeneDx Holdings Corp.Jun 2026$237.27M +27.1%-3.5%49.3%
BLLNBillionToOne, Inc.Jun 2026$192.89M +34.4%—26.4%
MDXHMDxHealth S.A.Jun 2026$162.49M +14.8%+13.4%123.0%
FLGTFulgent Genetics, Inc.Mar 2026$112.22M +35.2%-2.8%9.7%
CSTLCastle Biosciences, Inc.Mar 2026$86.39M +40.7%+30.7%15.8%
PSNLPersonalis, Inc.Mar 2026$70.63M +7.1%-0.7%21.7%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$51.12M +1.9%-1.8%126.4%
Peer median (excluding WGS) $137.35M+13.2%-0.7%34.1%

Competitors are the stored peer set for WGS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents400.57M137.4M99.68M85.21M105M
Short-term Investments0030.47M55.97M66.29M
Net Receivables26.56M43.34M32.82M37.63M74.37M
Inventory33.46M13.67M8.78M10.65M13.95M
Other Current Assets3.8M6.39M1.96M1.08M1.51M
Total Current Assets483.54M212.62M182.34M197.97M268.29M
Property, Plant & Equipment (Net)62.72M84.29M59.38M58.51M69.11M
Goodwill000013.52M
Intangible Assets0186.65M172.63M158.6M168.48M
Long-term Investments900K900K000
Tax Assets054.32M0046.48M
Other Non-current Assets6.93M6.48M4.41M4.31M3.32M
Total Non-current Assets70.55M332.64M236.42M221.41M301.9M
Total Assets554.09M545.26M418.76M419.38M570.19M
Account Payables44.69M46.02M10.24M7.95M2.46M
Short-term Debt3.42M10.87M497K08.95M
Tax Payables00000
Deferred Revenue473K40K000
Other Current Liabilities52.7M67.08M30.88M30.42M67.86M
Total Current Liabilities101.28M144.3M58.82M54.82M108.91M
Long-term Debt11M6.25M52.69M51.91M86.95M
Deferred Tax Liabilities056.98M1.56M965K47.24M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities35.28M24.02M14.74M5.52M(37.14M)
Total Non-current Liabilities64.71M147.26M131.92M119.32M153.1M
Total Liabilities165.99M291.56M190.74M174.13M262.01M
Common Stock24K38K2K2K3K
Retained Earnings(575.44M)(1.12B)(1.3B)(1.35B)(1.37B)
Accumulated OCI00425K830K936K
Other Stockholders Equity00000
Minority Interest00000
Total Equity388.1M253.71M228.02M245.25M308.18M
Total Debt32.85M77.13M119.77M116.17M151.95M
Net Debt(367.72M)(60.27M)20.09M30.96M46.95M

GeneDx Holdings Corp.

NASDAQ:WGS

Intrinsic Alpha fair value

Locked

Current Price

$51.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.